Drug retention rate of Janus kinase inhibitors in patients with rheumatoid arthritis: the KEIO-RA cohort study

<p>This study aimed to investigate the effectiveness and safety of Janus kinase inhibitors (JAKis) in patients with rheumatoid arthritis (RA) in the real world. All consecutive patients with RA from the KEIO-RA cohort who had received a JAKi from July 2013 to June 2023 were included. We assess...

Mô tả đầy đủ

Đã lưu trong:

Chi tiết về thư mục
Tác giả chính:	Satoshi Takanashi (15221350) (author)
Tác giả khác:	Masatoshi Kawai (2074750) (author), Mitsuhiro Akiyama (3412106) (author), Yasushi Kondo (371654) (author), Shuntaro Saito (4519816) (author), Masaru Takeshita (6197132) (author), Jun Kikuchi (266172) (author), Hironari Hanaoka (3910738) (author), Yuko Kaneko (839653) (author)
Được phát hành:	2025
Những chủ đề:	Biochemistry Medicine Pharmacology Biotechnology Ecology Immunology Developmental Biology Science Policy Chemical Sciences not elsewhere classified Rheumatoid arthritis JAK inhibitors difficult-to-treat rheumatoid arthritis retention rates effectiveness safety
Các nhãn:	Thêm thẻ Không có thẻ, Là người đầu tiên thẻ bản ghi này!

Drug retention rate of Janus kinase inhibitors in patients with rheumatoid arthritis: the KEIO-RA cohort study

Những quyển sách tương tự